Back to Results

An Open-label, Randomized Phase 3 Study of MK-6482 Versus Everolimus in Participants with Advanced Renal Cell Carcinoma That Has Progressed After Prior PD-1/L1 and VEGF-Targeted Therapies

Study category: Cancer

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

Highlands Ranch Hospital
University of Colorado Hospital

Principal Investigator
Elaine Lam,  MD

Elaine Lam, MD

Study ID

Protocol Number: 19-2445

More information available at ClinicalTrials.gov: NCT04195750

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers